Dr Martens Plc (DOCMF) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Dr. Martens Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.098 Good morning and welcome to our FY24 results presentation, both here in the 00:00:05.098 -- 00:00:07.261 room and on the webcast. 00:00:07.261 -- 00:00:12.048 I'm absolutely delighted to be joined this morning by Giles Wilson, our new CFO, who 00:00:12.048 -- 00:00:15.072 joined us three weeks ago. Also in the room from Dr. 00:00:15.072 -- 00:00:18.097 Martens, we have Paul Mason, our chairman, 00:00:18.097 -- 00:00:23.104 and also E.J. Wakode, who's our chief brand officer and who will also succeed 00:00:23.104 -- 00:00:28.231 me as CEO later in this financial year. And also Bethany Barnes, our head of investor 00:00:28.231 -- 00:00:30.231 relations. 00:00:32.887 -- 00:00:37.273 So our agenda for today, I'm gonna provide a very short overview of what we're gonna 00:00:37.273 -- 00:00:41.037 talk about, and then I'm gonna hand over to Giles, who will take us through our financial 00:00:41.037 -- 00:00:46.983 results for the last year. And then I'll return to provide a business update. 00:00:52.632 -- 00:00:57.679 So FY24, as you'll hear from Giles, our FY24 results were in line with 00:00:57.679 -- 00:01:02.728 our guidance. However, our USA performance was disappointing, which dragged 00:01:02.728 -- 00:01:05.790 down overall group performance. 00:01:05.813 -- 00:01:11.821 FY25 is going to be a year of action, where we will focus on our USA action plans, 00:01:11.821 -- 00:01:16.988 on marketing, and on driving savings. And I'll cover this in detail later. 00:01:16.988 -- 00:01:19.071 Then in FY26, 00:01:19.071 -- 00:01:21.995 we will have Dr. Martens back into growth. 00:01:21.995 -- 00:01:26.258 With that, I'd like to hand over to Giles, who will take us through the numbers. 00:01:30.042 -- 00:01:35.208 Thank you, Kenny. And goo...